Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Amifostine shows a good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep an upward tendency.
The prevalence of target diseases, the increasing demand for early detection of incurable diseases and the emergence of innovative applications, the market of amifostine is rapidly developing, people's preference for instant testing and personalized drugs is growing, and cost-effective laboratory testing And the emergence of integrated analysis systems is expected to bring new opportunities to businessmen in this market.
This report elaborates on the current development of the Amifostine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Clinigen Group
Merro Pharmaceutical
Sun Pharmaceutical
Taj Pharmaceuticals
Luye Pharma
Mingren Pharma
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
400mg/Dose
500mg/Dose
Application:
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Amifostine Industry Overview
-
1.1.1 Amifostine Market Scope and Market Segments
-
1.1.2 Amifostine Industry Characteristics
-
1.1.3 Global and China Amifostine Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Amifostine Production Value and Growth Rate (2017-2028)
-
1.2 Global Amifostine Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 400mg/Dose
-
1.2.2 500mg/Dose
-
1.3 Global Amifostine Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Ovarian Cancer Adjuvant Therapy
-
1.3.2 Head and Neck Cancer Adjuvant Therapy
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Amifostine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Amifostine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Amifostine Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Amifostine Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Amifostine Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Amifostine Industry Porter's Five Forces Model Analysis
-
2.2.3 Amifostine Industry PEST Analysis
-
2.3 Amifostine Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Amifostine Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Amifostine Industry
Chapter 3 Global and China Amifostine Market, by Manufacturer
-
3.1 Global and China Amifostine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Amifostine Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Amifostine Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Amifostine Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Amifostine Market Top 3 Players
Chapter 4 Global and China Amifostine Market, by Type (2017-2028)
-
4.1 Amifostine Market Trend, by Type
-
4.2 Global Amifostine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Amifostine Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Amifostine Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Amifostine Price Trend, by Type (2017-2028)
-
4.3 China Amifostine Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Amifostine Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Amifostine Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Amifostine Price Trend, by Type (2017-2028)
Chapter 5 Global and China Amifostine Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Amifostine Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Amifostine Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Amifostine Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Amifostine Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Amifostine Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Amifostine Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Amifostine Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Amifostine Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Amifostine Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Amifostine Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Amifostine Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Amifostine Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Amifostine Market Analysis
-
7.1 North America Amifostine Market, by Type
-
7.2 North America Amifostine Market, by Application
-
7.3 North America Amifostine Market Analysis and Forecast, by Country
-
7.3.1 United States Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Amifostine Market Analysis
-
8.1 Europe Amifostine Market, by Type
-
8.2 Europe Amifostine Market, by Application
-
8.3 Europe Amifostine Market Analysis and Forecast, by Country
-
8.3.1 Germany Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Amifostine Market Analysis
-
9.1 APAC Amifostine Market, by Type
-
9.2 APAC Amifostine Market, by Application
-
9.3 APAC Amifostine Market Analysis and Forecast, by Country
-
9.3.1 China Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Amifostine Market Analysis
-
10.1 Latin America, Middle East and Africa Amifostine Market, by Type
-
10.2 Latin America, Middle East and Africa Amifostine Market, by Application
-
10.3 Latin America, Middle East and Africa Amifostine Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Amifostine Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Amifostine Company Profiles
-
11.1 Clinigen Group
-
11.1.1 Clinigen Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Clinigen Group Amifostine Product Profiles, Application and Specification
-
11.1.3 Clinigen Group Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Merro Pharmaceutical
-
11.2.1 Merro Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Merro Pharmaceutical Amifostine Product Profiles, Application and Specification
-
11.2.3 Merro Pharmaceutical Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Sun Pharmaceutical
-
11.3.1 Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Sun Pharmaceutical Amifostine Product Profiles, Application and Specification
-
11.3.3 Sun Pharmaceutical Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Taj Pharmaceuticals
-
11.4.1 Taj Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Taj Pharmaceuticals Amifostine Product Profiles, Application and Specification
-
11.4.3 Taj Pharmaceuticals Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Luye Pharma
-
11.5.1 Luye Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Luye Pharma Amifostine Product Profiles, Application and Specification
-
11.5.3 Luye Pharma Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Mingren Pharma
-
11.6.1 Mingren Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Mingren Pharma Amifostine Product Profiles, Application and Specification
-
11.6.3 Mingren Pharma Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Amifostine Industry Investment Prospect and Risk Assessment
-
12.1 Amifostine Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Amifostine Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure China Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Global Amifostine Production Value and Growth Rate (2017-2028)
-
Figure China Amifostine Production Value and Growth Rate (2017-2028)
-
Figure Global Amifostine Market Size and Growth Rate of 400mg/Dose (2017-2028)
-
Figure Global Amifostine Market Size and Growth Rate of 500mg/Dose (2017-2028)
-
Figure Global Amifostine Market Size and Growth Rate of Ovarian Cancer Adjuvant Therapy (2017-2028)
-
Figure Global Amifostine Market Size and Growth Rate of Head and Neck Cancer Adjuvant Therapy (2017-2028)
-
Figure Global Amifostine Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Amifostine Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Amifostine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Amifostine Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Amifostine Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Amifostine Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Amifostine Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Amifostine Market Share, by Manufacturer in 2021
-
Figure Global and China Amifostine Market Share, by Manufacturer in 2022
-
Table Global Amifostine Sales Volume, by Type (2017-2028)
-
Table Global Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure Global Amifostine Sales Volume Share, by Type (2017-2028)
-
Table Global Amifostine Sales Value, by Type (2017-2028)
-
Table Global Amifostine Sales Value Share, by Type (2017-2028)
-
Figure Global Amifostine Price Trend, by Type (2017-2028)
-
Table China Amifostine Sales Volume, by Type (2017-2028)
-
Table China Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure China Amifostine Sales Volume Share, by Type (2017-2028)
-
Table China Amifostine Sales Value, by Type (2017-2028)
-
Table China Amifostine Sales Value Share, by Type (2017-2028)
-
Figure China Amifostine Price Trend, by Type (2017-2028)
-
Table Global Amifostine Sales Volume, by Application (2017-2028)
-
Table Global Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure Global Amifostine Sales Volume Share, by Application (2017-2028)
-
Table Global Amifostine Sales Value, by Application (2017-2028)
-
Table Global Amifostine Sales Value Share, by Application (2017-2028)
-
Figure Global Amifostine Sales Value Share, by Application (2017-2028)
-
Table China Amifostine Sales Volume, by Application (2017-2028)
-
Table China Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure China Amifostine Sales Volume Share, by Application (2017-2028)
-
Table China Amifostine Sales Value, by Application (2017-2028)
-
Table China Amifostine Sales Value Share, by Application (2017-2028)
-
Figure China Amifostine Sales Value Share, by Application (2017-2028)
-
Figure China Amifostine Production, Import, Consumption and Export (2017-2022)
-
Figure North America Amifostine Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Amifostine Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Amifostine Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Amifostine Production, Import, Consumption and Export (2017-2022)
-
Table North America Amifostine Sales Volume, by Type (2017-2028)
-
Table North America Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure North America Amifostine Sales Volume Share, by Type (2017-2028)
-
Table North America Amifostine Sales Volume, by Application (2017-2028)
-
Table North America Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure North America Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure United States Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure United States Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Canada Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Amifostine Sales Value and Growth Rate (2017-2028)
-
Table Europe Amifostine Sales Volume, by Type (2017-2028)
-
Table Europe Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure Europe Amifostine Sales Volume Share, by Type (2017-2028)
-
Table Europe Amifostine Sales Volume, by Application (2017-2028)
-
Table Europe Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure Europe Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure Germany Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure UK Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure UK Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure France Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure France Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Italy Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Spain Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Poland Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Russia Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Amifostine Sales Value and Growth Rate (2017-2028)
-
Table APAC Amifostine Sales Volume, by Type (2017-2028)
-
Table APAC Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure APAC Amifostine Sales Volume Share, by Type (2017-2028)
-
Table APAC Amifostine Sales Volume, by Application (2017-2028)
-
Table APAC Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure APAC Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure China Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure China Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Japan Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure India Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure India Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Amifostine Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Amifostine Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Amifostine Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Amifostine Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Amifostine Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Amifostine Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Amifostine Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Amifostine Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Amifostine Sales Value and Growth Rate (2017-2028)
-
Table Clinigen Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Clinigen Group Product Profiles, Application and Specification
-
Table Clinigen Group Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merro Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merro Pharmaceutical Product Profiles, Application and Specification
-
Table Merro Pharmaceutical Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sun Pharmaceutical Product Profiles, Application and Specification
-
Table Sun Pharmaceutical Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Taj Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Taj Pharmaceuticals Product Profiles, Application and Specification
-
Table Taj Pharmaceuticals Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Luye Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Luye Pharma Product Profiles, Application and Specification
-
Table Luye Pharma Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mingren Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mingren Pharma Product Profiles, Application and Specification
-
Table Mingren Pharma Amifostine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
